Back to Directory
The NanoBioTechnology Hub
North West England
Founded 2025
Nanotechnology-based point-of-care cardiovascular diagnostics for decentralised healthcare
The NanoBioTechnology Hub is a Manchester-based developer of miniaturised point-of-care diagnostic devices using nanotechnology and biotechnology.
The company is developing an ultra-sensitive handheld device for pre-hospital cardiovascular biomarker analysis, using lateral flow technology and biointerfaced nanoparticles to support decentralised risk stratification and triage.
It also provides training and educational resources in nanobiotechnology, diagnostics and personalised medicine for professionals and industry partners, serving healthcare professionals, researchers and life science companies.